EP2046313A4 - Verwendung von naphthochinonen bei der behandlung und kontrolle von diabetes, insulinresistenz und hyperglykämie - Google Patents
Verwendung von naphthochinonen bei der behandlung und kontrolle von diabetes, insulinresistenz und hyperglykämieInfo
- Publication number
- EP2046313A4 EP2046313A4 EP07769053A EP07769053A EP2046313A4 EP 2046313 A4 EP2046313 A4 EP 2046313A4 EP 07769053 A EP07769053 A EP 07769053A EP 07769053 A EP07769053 A EP 07769053A EP 2046313 A4 EP2046313 A4 EP 2046313A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- naphtoquinones
- hyperglycemia
- diabetes
- treatment
- control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0601503 | 2006-07-10 | ||
SE0602611 | 2006-12-04 | ||
PCT/SE2007/050507 WO2008008033A1 (en) | 2006-07-10 | 2007-07-06 | The use of naphtoquinones in the treatment and control of diabetes, insulin resistance and hyperglycemia |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2046313A1 EP2046313A1 (de) | 2009-04-15 |
EP2046313A4 true EP2046313A4 (de) | 2012-01-25 |
Family
ID=38923504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07769053A Withdrawn EP2046313A4 (de) | 2006-07-10 | 2007-07-06 | Verwendung von naphthochinonen bei der behandlung und kontrolle von diabetes, insulinresistenz und hyperglykämie |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2046313A4 (de) |
WO (1) | WO2008008033A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2323649A4 (de) * | 2008-07-25 | 2011-09-07 | Univ Emory | Behandlung verschiedener leiden mit 7,8-dihydroxyflavon und derivaten davon |
US9040713B2 (en) | 2010-09-27 | 2015-05-26 | Emory University | Methods of managing blood sugar levels and compositions related thereto |
WO2014103321A1 (ja) * | 2012-12-26 | 2014-07-03 | 学校法人北里研究所 | Pdk4阻害剤及びその利用 |
WO2014103862A1 (ja) * | 2012-12-26 | 2014-07-03 | Nakajima Toshihiro | 肥満症予防又は治療剤,リウマチの予防又は治療剤 |
KR101760565B1 (ko) | 2015-06-10 | 2017-07-31 | 포항공과대학교 산학협력단 | Tenc1의 활성 억제제를 유효성분으로 포함하는 당뇨병성 근위축증의 예방 또는 치료용 약학적 조성물 |
US10588910B2 (en) | 2016-07-05 | 2020-03-17 | Vasthera Co. Ltd. | Pharmaceutical composition comprising epidithiodioxopiperazine compound or derivative thereof, or pharmaceutically acceptable salt thereof, for preventing or treating pulmonary hypertension |
KR102032739B1 (ko) * | 2018-01-31 | 2019-10-16 | 한림대학교 산학협력단 | 신규한 크리신 유도체 화합물을 유효성분으로 포함하는 당뇨합병증의 예방 또는 치료용 약학 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0638309A1 (de) * | 1993-07-14 | 1995-02-15 | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. | Proteische-ADP-Ribosidierung hemmende Stoffe geeignet zum Vorbeugen der Diabetes-Mellitus-Komplikationen |
EP0659883A2 (de) * | 1993-11-24 | 1995-06-28 | Ono Pharmaceutical Co., Ltd. | Protein p140 und dafür kodierende DNS |
JPH1045575A (ja) * | 1996-07-31 | 1998-02-17 | Kureha Chem Ind Co Ltd | シコニン含有hsp47合成抑制剤 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060070135A1 (en) * | 1998-07-24 | 2006-03-30 | Michel Tremblay | Compositions and methods for inhibiting the enzymatic activity of PTP-1B |
AU2002305926A1 (en) * | 2001-02-05 | 2002-10-08 | Exegenics Inc. | Cysteine protease inhibitors |
WO2003032969A2 (en) * | 2001-10-15 | 2003-04-24 | National Research Council Of Canada | Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
WO2003087399A1 (en) * | 2002-04-17 | 2003-10-23 | Glucox Ab | Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes |
KR20050036293A (ko) * | 2003-10-15 | 2005-04-20 | 동아제약주식회사 | 나프토퀴논계 화합물을 함유한 세포질형 이소시트릭산탈수소화효소 활성 저해제 및 비만과 고지혈증 예방 또는치료용 약학적 조성물 |
US7067659B2 (en) * | 2004-04-23 | 2006-06-27 | Duke University | Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof |
CA2565363A1 (en) * | 2004-05-06 | 2005-11-17 | Robert F. Hofmann | Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity |
-
2007
- 2007-07-06 WO PCT/SE2007/050507 patent/WO2008008033A1/en active Application Filing
- 2007-07-06 EP EP07769053A patent/EP2046313A4/de not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0638309A1 (de) * | 1993-07-14 | 1995-02-15 | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. | Proteische-ADP-Ribosidierung hemmende Stoffe geeignet zum Vorbeugen der Diabetes-Mellitus-Komplikationen |
EP0659883A2 (de) * | 1993-11-24 | 1995-06-28 | Ono Pharmaceutical Co., Ltd. | Protein p140 und dafür kodierende DNS |
JPH1045575A (ja) * | 1996-07-31 | 1998-02-17 | Kureha Chem Ind Co Ltd | シコニン含有hsp47合成抑制剤 |
Non-Patent Citations (3)
Title |
---|
DATABASE WPI Week 199817, Derwent World Patents Index; AN 1998-189155, XP002665579 * |
REIKO KAMEIA ET AL: "Shikonin Stimulates Glucose Uptake in 3T3-L1 Adipocytes via an Insulin-Independent Tyrosine Kinase Pathway", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 292, no. 3, 5 April 2002 (2002-04-05), pages 642 - 651, XP008102880, ISSN: 0006-291X, [retrieved on 20020402], DOI: 10.1006/BBRC.2002.6714 * |
See also references of WO2008008033A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2046313A1 (de) | 2009-04-15 |
WO2008008033A1 (en) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180667T1 (hr) | Protutijelo agonista kloto-beta za uporabu u liječenju dijabetesa ili otpornosti na inzulin | |
EP2120959A4 (de) | Verfahren und zusammensetzungen zur behandlung von insulinresistenz, diabetes und diabetesbedingter dyslipidämie | |
IL246402A (en) | A therapeutic component for treating obesity, diabetes and impaired glucose tolerance | |
EP1758597A4 (de) | Verwendung von arzneimittelkombinationen zur behandlung der insulinresistenz | |
GB0619860D0 (en) | Treatment of insulin resistance and disorders associated therewith | |
HK1113289A1 (en) | Composition for nutritionally improving glucose control and insulin action | |
IL211370A0 (en) | Treatment for diabetes in patients with insufficient glycemic control desptie therapy with an oral or non-oral antidiabetic drug | |
IL237314A (en) | Insulin polypeptides are modified and their uses | |
WO2006121921A8 (en) | Infusion device and method with disposable portion | |
IL215925A0 (en) | Electrokinetically-altered fluid compositions and use thereof for treating insulin resistance and diabetes mellitus | |
WO2010049678A3 (en) | Treatment of energy utilization diseases | |
EP2046313A4 (de) | Verwendung von naphthochinonen bei der behandlung und kontrolle von diabetes, insulinresistenz und hyperglykämie | |
EP1799263A4 (de) | Reduzierung von er-stress bei der behandlung von adipositas und diabetes | |
EP1733749A4 (de) | Spritze mit konnektor, konnektor für spritze und spritze | |
PL2419097T3 (pl) | Kompozycja farmaceutyczna zawierająca (1S)-1,5-anhydro-1-[5-(4-etoksybenzylo)-2-metoksy-4-metylofenylo]-1-tio-D-glucitol i metforminę oraz jej zastosowanie w leczeniu cukrzycy | |
ZA201000990B (en) | Herbal formulations for controlling blood glucose levels in patients with diabetes | |
EP2000164A4 (de) | Sich selbst zerstörende einwegspritze und selbstzerstörungsverfahren dafür | |
EP1890708A4 (de) | Glucose-induzierbare insulinexpression und behandlungsmethoden für diabetes | |
EP2203169A4 (de) | Glykämische kontrolle, diabetes-behandlung und andere behandlungen mit acetylcholinesterase-hemmern | |
WO2006007400A9 (en) | Methods of diagnosing and treating obesity, diabetes and insulin resistance | |
ZA200900581B (en) | Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia | |
HK1076721A1 (en) | A chinese traditional medical composition for treating diabetes and method for preparing the same | |
EP1872815A4 (de) | Kontinuierliche subkutane insulin-infusionstherapie | |
ZA201007061B (en) | Pyridopyrazinones derivatives insulin secretion stimulators,methods for obtaining them and use thereof for the treatment of diabetes | |
EP2440233A4 (de) | Sorcs1-ähnlicher wirkstoff zur verwendung bei der behandlung von insulinresistenz und damit zusammenhängenden erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090210 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20111227 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 3/08 20060101ALN20111219BHEP Ipc: A61P 3/06 20060101ALN20111219BHEP Ipc: A61P 3/04 20060101ALN20111219BHEP Ipc: A61P 3/10 20060101ALI20111219BHEP Ipc: A61K 31/37 20060101ALI20111219BHEP Ipc: A61K 31/122 20060101AFI20111219BHEP |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20130425 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160503 |